B · Normal
[Hong Kong IPO: Dizhe (Jiangsu) Pharmaceutical Co., Ltd. submitted to the Hong Kong Stock Exchange] On August 27, Livermore Securities showed that Dizhe (Jiangsu) Pharmaceutical Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange, and the joint sponsors were Goldman Sachs and Huatai International.
Comments